These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3123451)

  • 1. Branhamella catarrhalis: beta-lactamase production and sensitivity to oral antibiotics, including new cephalosporins.
    Stobberingh EE; Wunderink M; Philips M; Houben A
    J Antimicrob Chemother; 1987 Nov; 20(5):765-6. PubMed ID: 3123451
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
    Christensen JJ; Keiding J; Bruun B
    APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
    Schmitz FJ; Boos M; Mayer S; Verhoef J; Milatovic D; Fluit AC
    J Antimicrob Chemother; 2002 Jan; 49(1):220-3. PubMed ID: 11751796
    [No Abstract]   [Full Text] [Related]  

  • 5. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
    Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
    J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern.
    Fung CP; Yeo SF; Livermore DM
    J Antimicrob Chemother; 1994 Feb; 33(2):215-22. PubMed ID: 8182002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of nine oral antibiotics against Branhamella catarrhalis clinical isolates.
    Paraskaki I; Lebessi E; Dellyanni V; Kafetzis DA
    J Chemother; 1995 Nov; 7 Suppl 4():69-70. PubMed ID: 8904112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 10. The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children.
    Suzuki K; Baba S; Inagaki M; Kobayashi T
    Auris Nasus Larynx; 1988; 15(2):105-11. PubMed ID: 3144965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
    Yeo SF; Livermore DM
    J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.
    Wallace RJ; Nash DR; Steingrube VA
    Am J Med; 1990 May; 88(5A):46S-50S. PubMed ID: 2111092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital.
    Yamada K; Arai K; Saito R
    J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
    Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
    Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of roxithromycin against Branhamella catarrhalis.
    Spencer RC; Wheat PF
    J Antimicrob Chemother; 1990 Jul; 26(1):153-5. PubMed ID: 2120171
    [No Abstract]   [Full Text] [Related]  

  • 18. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults.
    Khan MA; Northwood JB; Levy F; Verhaegh SJ; Farrell DJ; Van Belkum A; Hays JP
    J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action.
    Wise R; Andrews JM; Ashby JP; Thornber D
    J Antimicrob Chemother; 1990 Aug; 26(2):209-13. PubMed ID: 2120175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.